Citation: Jm. Barret et Bt. Hill, DNA-REPAIR MECHANISMS ASSOCIATED WITH CELLULAR-RESISTANCE TO ANTITUMOR DRUGS - POTENTIAL NOVEL TARGETS, Anti-cancer drugs, 9(2), 1998, pp. 105-123
Authors:
BARRET JM
ETIEVANT C
LIMOUZY A
CABROL N
VINCENTI M
HILL BT
Citation: Jm. Barret et al., IN-VITRO SYNERGISTIC EFFECTS OF ANTICANCER DRUGS IN COMBINATION WITH VINFLUNINE, A NOVEL FLUORINATED VINCA ALKALOID, Annals of oncology, 9, 1998, pp. 392-392
Authors:
ETIEVANT C
KRUCZYNSKI A
BARRET JM
ASTRUC J
CHAZOTTES E
CASSABOIS V
RIGAUD S
LIMOUZY A
HILL BT
Citation: C. Etievant et al., MECHANISMS OF MULTIDRUG-RESISTANCE IN VINFLUNINE-RESISTANT MURINE P388 VFL CELLS, ESTABLISHED IN-VIVO/, Annals of oncology, 9, 1998, pp. 566-566
Authors:
ETIEVANT C
SCHAMBEL P
GUMINSKI Y
BARRET JM
IMBERT T
HILL BT
Citation: C. Etievant et al., REQUIREMENTS FOR P-GLYCOPROTEIN RECOGNITION BASED ON STRUCTURE-ACTIVITY-RELATIONSHIPS IN THE PODOPHYLLOTOXIN SERIES, Anti-cancer drug design, 13(4), 1998, pp. 317-336
Authors:
ETIEVANT C
BARRET JM
KRUCZYNSKI A
PERRIN D
HILL BT
Citation: C. Etievant et al., VINFLUNINE (20',20'-DIFLUORO-3',4'-DIHYDROVINORELBINE), A NOVEL VINCAALKALOID, WHICH PARTICIPATES IN P-GLYCOPROTEIN (PGP)-MEDIATED MULTIDRUG-RESISTANCE IN-VIVO AND IN-VITRO, Investigational new drugs, 16(1), 1998, pp. 3-17
Authors:
KRUCZYNSKI A
BARRET JM
ETIEVANT C
COLPAERT F
FAHY J
HILL BT
Citation: A. Kruczynski et al., ANTIMITOTIC AND TUBULIN-INTERACTING PROPERTIES OF VINFLUNINE, A NOVELFLUORINATED VINCA ALKALOID, Biochemical pharmacology, 55(5), 1998, pp. 635-648
Citation: Jm. Barret et al., EVALUATION OF DNA-REPAIR INHIBITION BY ANTITUMOR OR ANTIBIOTIC DRUGS USING A CHEMILUMINESCENCE MICROPLATE ASSAY, Carcinogenesis, 18(12), 1997, pp. 2441-2445
Citation: Jm. Barret et al., DNA-REPAIR ACTIVITY IN PROTEIN EXTRACTS OF FRESH HUMAN-MALIGNANT LYMPHOID-CELLS, Molecular pharmacology, 49(5), 1996, pp. 766-771
Citation: Jm. Barret et al., DEFICIENT NUCLEOTIDE EXCISION-REPAIR ACTIVITY IN PROTEIN EXTRACTS FROM NORMAL HUMAN-LYMPHOCYTES, Carcinogenesis, 16(7), 1995, pp. 1611-1616
Authors:
MULLER C
FRANCONI F
AKOKA S
GUESNET J
BARRET JM
BEAU P
Citation: C. Muller et al., ASSESSMENT OF EPIDERMIS MOISTURE-CONTENT BY MAGNETIC-RESONANCE-IMAGING, Journal of investigative dermatology, 104(1), 1995, pp. 165-165
Authors:
ERNOULD AP
FERRY G
BARRET JM
GENTON A
BOUTIN JA
Citation: Ap. Ernould et al., SUBSTRATE PHOSPHORYLATION CAPACITIES OF THE MAJOR TYROSINE PROTEIN-KINASE FROM THE HUMAN PROMYELOCYTIC CELL-LINE, HL-60, International journal of peptide & protein research, 43(5), 1994, pp. 496-504
Authors:
LEVY E
BAROCHE C
BARRET JM
ALAPETITE C
SALLES B
AVERBECK D
MOUSTACCHI E
Citation: E. Levy et al., ACTIVATED RAS ONCOGENE AND SPECIFICALLY ACQUIRED-RESISTANCE TO CISPLATIN IN HUMAN MAMMARY EPITHELIAL-CELLS - INDUCTION OF DNA CROSS-LINKS AND THEIR REPAIR, Carcinogenesis, 15(5), 1994, pp. 845-850
Citation: Jm. Barret et al., A CISPLATIN-RESISTANT MURINE LEUKEMIA-CELL LINE EXHIBITS INCREASED TOPOISOMERASE-II ACTIVITY, Molecular pharmacology, 46(3), 1994, pp. 431-436
Authors:
ALAPETITE C
LEVY E
BAROCHE C
BARRET JM
SALLES B
AVERBECK D
MOUSTACCHI E
Citation: C. Alapetite et al., AN ACTIVATED RAS ONCOGENE DID NOT MODIFY THE RADIOSENSITIVITY OF A HUMAN MAMMARY EPITHELIAL-CELL LINE BUT PRODUCED A SPECIFIC ACQUIRED-RESISTANCE TO CDDP, International journal of radiation oncology, biology, physics, 27, 1993, pp. 303-304
Authors:
ERNOULD AP
FERRY G
BARRET JM
GENTON A
BOUTIN JA
Citation: Ap. Ernould et al., PURIFICATION AND CHARACTERIZATION OF THE MAJOR TYROSINE PROTEIN-KINASE FROM THE HUMAN PROMYELOCYTIC CELL-LINE, HL-60, European journal of biochemistry, 214(2), 1993, pp. 503-514
Authors:
BARRET JM
ERNOULD AP
FERRY G
GENTON A
BOUTIN JA
Citation: Jm. Barret et al., INTEGRATED SYSTEM FOR THE SCREENING OF THE SPECIFICITY OF PROTEIN-KINASE INHIBITORS, Biochemical pharmacology, 46(3), 1993, pp. 439-448